What is the initial management and complete list of medications for a patient in a code blue situation due to a suspected drug overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Code Blue Drug Overdose: Complete Medication List and Management Protocol

In a code blue drug overdose situation, the complete medication list includes: epinephrine 1 mg IV/IO every 3-5 minutes for cardiac arrest, naloxone 0.4-2 mg IV/IO/IM for opioid overdose, and specific antidotes based on the suspected toxin, with standard ACLS medications (amiodarone 300 mg or lidocaine 1-1.5 mg/kg for refractory VF/pVT) used according to cardiac rhythm. 1

Immediate Assessment and Drug Administration Algorithm

Standard ACLS Medications (All Drug Overdose Cardiac Arrests)

Core resuscitation medications:

  • Epinephrine 1 mg IV/IO every 3-5 minutes - administered throughout the resuscitation for all cardiac arrest rhythms 1
  • Amiodarone 300 mg IV/IO bolus (first dose), then 150 mg (second dose) - for refractory VF/pVT only 1
  • Lidocaine 1-1.5 mg/kg IV/IO (first dose), then 0.5-0.75 mg/kg (second dose) - alternative to amiodarone for refractory VF/pVT 1
  • Atropine - not routinely recommended in standard cardiac arrest but may be considered for specific toxidromes 1

Toxin-Specific Antidotes for Critical Poisoning

Opioid overdose:

  • Naloxone 0.4-2 mg IV/IO/IM - initial dose, repeat every 2-3 minutes if inadequate response 1
  • Naloxone 2-4 mg intranasal - repeat every 2-3 minutes as needed 1
  • Naloxone infusion: two-thirds of the waking dose per hour - for sustained effect after initial reversal 1

Benzodiazepine overdose:

  • Flumazenil 0.2 mg IV, titrated up to 1 mg total - only in select patients without contraindications 1
  • Pediatric dose: 0.01 mg/kg (up to 0.2 mg) 2
  • Critical caveat: Multiple contraindications exist - do not use in patients with seizure history, chronic benzodiazepine use, or suspected co-ingestion with tricyclic antidepressants 1

Beta-blocker/Calcium channel blocker overdose:

  • Calcium chloride 2000 mg (20 mL of 100 mg/mL solution) - initial dose 1
  • Maintenance infusion: 20-40 mg/kg/h 1
  • Calcium gluconate 6000 mg (60 mL of 100 mg/mL solution) - alternative to calcium chloride 1
  • Glucagon 2-10 mg IV/IO - initial bolus, followed by 1-15 mg/h infusion 1
  • High-dose insulin 1 U/kg bolus - followed by 1-10 U/kg/h infusion with dextrose supplementation 1
  • Atropine 0.5-1.0 mg every 3-5 minutes up to 3 mg - for bradycardia 1

Digoxin/cardiac glycoside overdose:

  • Digoxin immune Fab 10-20 vials - for acute overdose when critically ill and ingested dose unknown 1
  • Calculated dosing: 1 vial for every 0.5 mg digoxin ingested 1

Sodium channel blocker overdose (tricyclic antidepressants, cocaine):

  • Sodium bicarbonate 50-150 mEq IV bolus - titrate to QRS narrowing 1
  • Maintenance infusion: 150 mEq/L solution at 1-3 mL/kg/h 1

Local anesthetic toxicity:

  • Intravenous lipid emulsion (ILE) 1.5 mL/kg (up to 100 mL) of 20% solution - initial bolus 1
  • Infusion: 0.25 mL/kg/min for up to 30 minutes 1

Organophosphate/carbamate poisoning:

  • Atropine 1-2 mg, doubled every 5 minutes - titrate to reversal of bronchorrhea and bronchospasm 1
  • Maintenance: 10-20% of total loading dose per hour 1
  • Pralidoxime 1-2 g IV - followed by 400-600 mg/h infusion 1

Cyanide poisoning:

  • Hydroxocobalamin 5 g IV - initial dose 1
  • Sodium nitrite 300 mg IV - alternative, monitor for hypotension 1
  • Sodium thiosulfate 12.5 g IV - adjunctive therapy 1

Methemoglobinemia:

  • Methylene blue 1-2 mg/kg IV - repeat every hour if needed, maximum 5-7 mg/kg 1

Critical Decision Points and Pitfalls

Priority hierarchy in drug overdose cardiac arrest:

  1. High-quality CPR takes absolute priority over all medications 1, 3, 4
  2. Establish IV/IO access immediately 1
  3. Administer epinephrine every 3-5 minutes per standard ACLS 1
  4. Consider toxin-specific antidotes only after initiating standard resuscitation 1, 4

Common pitfalls to avoid:

  • Never delay CPR to administer naloxone - standard resuscitative measures take priority 3, 4, 5
  • Do not administer flumazenil in undifferentiated overdose - risk of precipitating seizures in mixed ingestions with tricyclic antidepressants or in patients with chronic benzodiazepine use 1
  • Always administer naloxone first when combined opioid-benzodiazepine overdose is suspected - before considering flumazenil 1
  • Monitor for resedation after naloxone - naloxone's duration of action (30-90 minutes) is shorter than most opioids, requiring continuous infusion or repeated doses 1, 3
  • Titrate naloxone to respiratory effort, not full consciousness - using the lowest effective dose minimizes acute withdrawal in opioid-dependent patients 1, 5

Addressing reversible causes (the H's and T's):

  • Toxins is specifically listed as a reversible cause in the AHA algorithm 1
  • Consider other reversible causes: hypovolemia, hypoxia, hydrogen ion (acidosis), hypo/hyperkalemia, hypothermia, tension pneumothorax, tamponade, thrombosis (pulmonary/coronary) 1

Post-Resuscitation Monitoring Requirements

Observation periods after antidote administration:

  • Naloxone: minimum 2 hours observation - longer for long-acting opioids (methadone, sustained-release formulations) 3, 4, 5
  • Flumazenil: continuous monitoring until risk of resedation is low - resedation occurred in 7-15% of patients in clinical trials 2
  • All overdose patients: monitor until vital signs normalized and risk of recurrent toxicity is low 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Opioid Poisoning Treatment Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Initial Management of Drug Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Naloxone Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.